Published in Cancer Weekly, April 17th, 2001
Malignant glioma is a devastating disease, where the mean patient survival is between five and 10 months and existing treatment regimens are largely ineffective. EG009 treatment involves the post-surgical application of a herpes simplex virus thymidine kinase (HSV-tk)-based gene therapy, followed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.